Austin Health

Title
The diverse pleiotropic effects of spliceosomal protein PUF60: A case series of Verheij syndrome.
Publication Date
2022-12
Author(s)
Fennell, Andrew Paul
Baxter, Anne Elizabeth
Berkovic, Samuel Frank
Ellaway, Carolyn Jane
Forwood, Caitlin
Hildebrand, Michael S
Kumble, Smitha
McKeown, Colina
Mowat, David
Poke, Gemma
Rajagopalan, Sulekha
Regan, Brigid M
Scheffer, Ingrid E
Stark, Zornitza
Stutterd, Chloe Alice
Tan, Tiong Yang
Wilkins, Ella Jane
Yeung, Alison
Hunter, Matthew Frank
Subject
8q24.3
PUF60
Verheij syndrome
craniofacial spliceosomopathy
spliceosomal disorder
Type of document
Journal Article
OrcId
0000-0001-6744-1810
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0003-4580-841X
0000-0002-5752-5698
0000-0003-0131-1954
0000-0003-2739-0515
0000-0001-6605-3322
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-3730-0870
0000-0002-8748-4866
0000-0002-5559-9466
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-2311-2174
0000-0001-8640-1371
0000-0002-2525-1936
0000-0001-8455-7778
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-5793-6016
0000-0002-2475-6545
DOI
10.1002/ajmg.a.62950
Abstract
Verheij syndrome (VRJS) is a rare craniofacial spliceosomopathy presenting with craniofacial dysmorphism, multiple congenital anomalies and variable neurodevelopmental delay. It is caused by single nucleotide variants (SNVs) in PUF60 or interstitial deletions of the 8q24.3 region. PUF60 encodes a splicing factor which forms part of the spliceosome. To date, 36 patients with a sole diagnosis of VRJS due to disease-causing PUF60 SNVs have been reported in peer-reviewed publications. Although the depth of their phenotyping has varied greatly, they exhibit marked phenotypic heterogeneity. We report 10 additional unrelated patients, including the first described patients of Khmer, Indian, and Vietnamese ethnicities, and the eldest patient to date, with 10 heterozygous PUF60 variants identified through exome sequencing, 8 previously unreported. All patients underwent deep phenotyping identifying variable dysmorphism, growth delay, neurodevelopmental delay, and multiple congenital anomalies, including several unique features. The eldest patient is the only reported individual with a germline variant and neither neurodevelopmental delay nor intellectual disability. In combining these detailed phenotypic data with that of previously reported patients (n = 46), we further refine the known frequencies of features associated with VRJS. These include neurodevelopmental delay/intellectual disability (98%), axial skeletal anomalies (74%), appendicular skeletal anomalies (73%), oral anomalies (68%), short stature (66%), cardiac anomalies (63%), brain malformations (48%), hearing loss (46%), microcephaly (41%), colobomata (38%), and other ocular anomalies (65%). This case series, incorporating three patients from previously unreported ethnic backgrounds, further delineates the broad pleiotropy and mutational spectrum of PUF60 pathogenic variants.
Link
Citation
American Journal of Medical Genetics. Part A 2022; 188(12)
Jornal Title
American Journal of Medical Genetics. Part A
ISSN
1552-4833

Files:

NameSizeformatDescriptionLink